OncoC4 was founded by Yang Liu, Pan Zheng in 2020.

Who are OncoC4's investors?

OncoC4's investors include 3E Bioventures Capital, HM Venture Partners.

Where is OncoC4 headquartered?

OncoC4 is headquartered in Rockville, US.

OncoC4

Rockville, US · Founded 2020 · Delaware corporation · 2 known investors

OncoC4 is a clinical-stage biopharmaceutical company developing immunotherapy treatments for cancer patients, based on research by its immunologist founders. It advances its pipeline through internal R&D and external partnerships, including a collaboration with BioNTech to develop and commercialize gotistobart.

Biotech Healthtech

Founders & leadership

OncoC4 was founded in 2020 by Yang Liu and Pan Zheng.

Yang LiuCo-founder

Pan ZhengCo-founder

Martin DevenportNamed on SEC filing

Michael FlaschenNamed on SEC filing

Investors · 2

3E Bioventures CapitalPalo Alto

HM Venture PartnersSan Francisco

Reported raises · per SEC filings

Form D private placements

▶$50MofferedJan 2021 · 1 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Martin DevenportExecutive Officer
Yang LiuExecutive Officer, Director
Michael FlaschenDirector

Offering amount: $50M
First sale: Dec 2020
Incorporated: Corporation, Delaware, 2020
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Oup26 shared keywordsOxford University Press publishes research, educational, and reference materials, including reports on reading and children's learning, and reference resources such as its dictionary "Word of the Day." It serves readers, educators, and learners across a wide range of subjects worldwide.

Companies competing with OncoC4 for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does OncoC4 do?: OncoC4 is a clinical-stage biopharmaceutical company developing immunotherapy treatments for cancer patients, based on research by its immunologist founders. It advances its pipeline through internal R&D and external partnerships, including a collaboration with BioNTech to develop and commercialize gotistobart.
Who founded OncoC4?: OncoC4 was founded by Yang Liu, Pan Zheng in 2020.
Who are OncoC4's investors?: OncoC4's investors include 3E Bioventures Capital, HM Venture Partners.
Where is OncoC4 headquartered?: OncoC4 is headquartered in Rockville, US.